Eli Lilly and Company Logo

Eli Lilly and Company (1LLY)

MTA

Currency in EUR
1,074.60
-13.40 (-1.23%)

Real-time Data

07:00 AM

Day's Range

1,074.60
1,074.60

52 wk Range

595.80
1,106.80

Overview - 1LLY - Eli Lilly and Company

Key Statistics

Valuation

Enterprise Value

866.47B

P/E (Trailing)

‪42.54‬

PEG Ratio

‪1.62‬

Price / Sales (TTM)

‪12.15‬

Price / Book

‪33.36‬

EV / EBITDA

‪24.31‬

Profitability

Gross Margin

‪85.77%‬

Profit Margin

‪33.52%‬

Operating Margin

‪54.22%‬

Return on Assets

‪20.35%‬

Return on Equity

‪102.28%‬

Ownership

Shares Outstanding

891.50M

Float

888.95M

Held by Insiders

‪0.15%‬

Held by Institutions

‪85.41%‬

Price stats

Beta

‪0.50‬

50-Day Avg

‪1,028.91‬

200-Day Avg

‪911.27‬

Dividends

Payout Ratio

‪21.69%‬

Frequency

Quarterly

Market Cap - 1LLY - Eli Lilly and Company

Peers - 1LLY - Eli Lilly and Company

Peer Comparison

Compared with companies in Drug Manufacturers - General listed on MTA.

Profile Summary - 1LLY - Eli Lilly and Company

About

Eli Lilly and Company is a leading pharmaceutical company engaged in the discovery, development, manufacture, and sale of human pharmaceutical products. It focuses on innovative medicines addressing critical health needs in areas such as diabetes, oncology, immunology, neuroscience, obesity, cardiovascular diseases,…

SectorHealthcare
IndustryDrug Manufacturers - General
Employees50K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.